|
F9775A |
14 |
0.48 |
0.42 |
0.65 |
0.0 |
Glyco:0/2 * Cl:0/2 |
MIBiG |
Source |
CC1=CC(=O)C2(O)C(=O)C3=C(O)C(=O)C4=C(Oc5cc(C)cc(O)c5O4)C3(C)C12 |
view |
F9775A |
|
|
F9775B |
15 |
0.48 |
0.42 |
0.65 |
0.0 |
Glyco:0/2 * Cl:0/2 |
MIBiG |
Source |
CC1=CC(=O)C2(O)C(=O)C3=C(O)C(=O)C4=C(Oc5c(O)cc(C)cc5O4)C3(C)C12 |
view |
F9775B |
|
|
Fluostatin H |
16 |
0.48 |
0.41 |
0.65 |
0.0 |
Glyco:0/2 * Cl:0/2 |
MIBiG |
Source |
CCCC(C)C(=O)O[C@H]1c2c(cc(O)c3c2C(=O)c2cccc(O)c2-3)C(=O)[C@]2(C)O[C@H]12 |
view |
Fluostatin H |
|
|
Xenocyloin B |
17 |
0.48 |
0.42 |
0.64 |
0.0 |
Glyco:0/2 * Cl:0/2 |
MIBiG |
Source |
CCC(C)C(=O)[C@@H](O)Cc1c[nH]c2ccccc12 |
view |
Xenocyloin B |
|
|
chloramphenicol |
18 |
0.48 |
0.41 |
0.49 |
0.67 |
Glyco:0/2 * Cl:2/2 |
MIBiG |
Source |
O=C(N[C@H](CO)[C@H](O)c1ccc([N+](=O)[O-])cc1)C(Cl)Cl |
view |
chloramphenicol |
|
|
Mensacaricin |
19 |
0.47 |
0.41 |
0.64 |
0.0 |
Glyco:0/2 * Cl:0/2 |
MIBiG |
Source |
COc1cccc2c1[C@H](OC)[C@]13O[C@@]1(C2=O)[C@H](O)[C@H](C)[C@@](O)(C(=O)[C@@H]1O[C@H]1C)[C@@H]3O |
view |
Mensacaricin |
|
|
nogalonic acid methyl ester |
35 |
0.42 |
0.43 |
0.51 |
0.0 |
Glyco:0/2 * Cl:0/2 |
MIBiG |
Source |
COC(=O)Cc1cc2c(c(O)c1C(=O)CC(C)=O)C(=O)c1c(O)cccc1C2=O |
view |
nogalonic acid methyl ester |
|
|
nogalavinone |
36 |
0.42 |
0.43 |
0.51 |
0.0 |
Glyco:0/2 * Cl:0/2 |
MIBiG |
Source |
COC(=O)[C@@H]1c2cc3c(c(O)c2[C@@H](O)C[C@]1(C)O)C(=O)c1c(O)cccc1C3=O |
view |
nogalavinone |
|
|
aspyridone A |
33 |
0.42 |
0.4 |
0.54 |
0.0 |
Glyco:0/2 * Cl:0/2 |
MIBiG |
Source |
CC[C@H](C)C[C@H](C)C(=O)c1c(O)c(-c2ccc(O)cc2)c[nH]c1=O |
view |
aspyridone A |
|
|
1-(2,3,5,10-tetrahydroxy-7-methoxy-4-oxo-1,2,3,4-tetrahydroanthracen-2-yl)pentane-2,4-dione |
34 |
0.42 |
0.43 |
0.52 |
0.0 |
Glyco:0/2 * Cl:0/2 |
MIBiG |
Source |
COc1cc(O)c2c(O)c3c(cc2c1)CC(O)(CC(=O)CC(C)=O)C(O)C3=O |
view |
1-(2,3,5,10-tetrahydroxy-7-methoxy-4-oxo-1,2,3,4-tetrahydroanthracen-2-yl)pentane-2,4-dione |
|
|
Xenocyloin A |
12 |
0.48 |
0.4 |
0.66 |
0.0 |
Glyco:0/2 * Cl:0/2 |
MIBiG |
Source |
CC(C)C(=O)[C@@H](O)Cc1c[nH]c2ccccc12 |
view |
Xenocyloin A |
|
|
physostigmine |
13 |
0.48 |
0.42 |
0.65 |
0.0 |
Glyco:0/2 * Cl:0/2 |
MIBiG |
Source |
CNC(=O)Oc1ccc2c(c1)[C@]1(C)CCN(C)[C@@H]1N2C |
view |
physostigmine |
|
|
4-desmethylgriseofulvin |
0 |
0.56 |
0.41 |
0.72 |
0.4 |
Glyco:0/2 * Cl:1/2 |
MIBiG |
Source |
COC1=CC(=O)C[C@@H](C)[C@]12Oc1c(Cl)c(OC)cc(O)c1C2=O |
view |
4-desmethylgriseofulvin |
|
|
aspirochlorine |
1 |
0.56 |
0.42 |
0.71 |
0.4 |
Glyco:0/2 * Cl:1/2 |
MIBiG |
Source |
CON1C(=O)[C@H]2NC(=O)[C@]13Oc1cc(O)c(Cl)cc1[C@@H]3SS2 |
view |
aspirochlorine |
|
|
Xenocyloin C |
2 |
0.55 |
0.44 |
0.76 |
0.0 |
Glyco:0/2 * Cl:0/2 |
MIBiG |
Source |
CC(=O)O[C@@H](Cc1c[nH]c2ccccc12)C(=O)C(C)C |
view |
Xenocyloin C |
|
|
Xenocyloin D |
3 |
0.54 |
0.44 |
0.74 |
0.0 |
Glyco:0/2 * Cl:0/2 |
MIBiG |
Source |
CCC(C)C(=O)[C@H](Cc1c[nH]c2ccccc12)OC(C)=O |
view |
Xenocyloin D |
|
|
Xenocoumacin II |
4 |
0.53 |
0.43 |
0.74 |
0.0 |
Glyco:0/2 * Cl:0/2 |
MIBiG |
Source |
CC(C)CC(NC(=O)C(O)C(O)C1CCCN1)C1Cc2cccc(O)c2C(=O)O1 |
view |
Xenocoumacin II |
|
|
hygromycin B |
5 |
0.53 |
0.42 |
0.74 |
0.0 |
Glyco:0/2 * Cl:0/2 |
MIBiG |
Source |
CC(=O)[C@H]1O[C@@H](Oc2ccc(/C=C(\C)C(=O)N[C@@H]3[C@H](O)[C@@H](O)[C@H]4OCO[C@H]4[C@@H]3O)cc2O)[C@@H](O)[C@@H]1O |
view |
hygromycin B |
|
|
frenolicin |
6 |
0.53 |
0.43 |
0.73 |
0.0 |
Glyco:0/2 * Cl:0/2 |
MIBiG |
Source |
CCC[C@H]1O[C@@H]2CC(=O)O[C@@H]2C2=C1C(=O)c1c(O)cccc1C2=O |
view |
frenolicin |
|
|
dhurrin |
7 |
0.53 |
0.41 |
0.65 |
0.4 |
Glyco:1/2 * Cl:0/2 |
MIBiG |
Source |
N#C[C@@H](O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)c1ccc(O)cc1 |
view |
dhurrin |
|
|
hypothemycin |
8 |
0.5 |
0.41 |
0.7 |
0.0 |
Glyco:0/2 * Cl:0/2 |
MIBiG |
Source |
COc1cc(O)c2c(c1)[C@H](O)C(O)CC1OC1C(=O)/C=C\CC(C)OC2=O |
view |
hypothemycin |
|
|
tomaymycin |
9 |
0.5 |
0.41 |
0.69 |
0.0 |
Glyco:0/2 * Cl:0/2 |
MIBiG |
Source |
C/C=C1\CC2C(OC)Nc3cc(O)c(OC)cc3C(=O)N2C1 |
view |
tomaymycin |
|
|
dehydrocurvularin |
10 |
0.5 |
0.4 |
0.69 |
0.0 |
Glyco:0/2 * Cl:0/2 |
MIBiG |
Source |
C[C@H]1CCC/C=C\C(=O)c2c(O)cc(O)cc2CC(=O)O1 |
view |
dehydrocurvularin |
|
|
Xenocoumacin 1 |
11 |
0.49 |
0.41 |
0.67 |
0.0 |
Glyco:0/2 * Cl:0/2 |
MIBiG |
Source |
CC(C)CC(NC(=O)C(O)C(O)C(N)CCCN=C(N)N)C1Cc2cccc(O)c2C(=O)O1 |
view |
Xenocoumacin 1 |
|
|
4-hydroxy-3-nitrosobenzamide |
20 |
0.47 |
0.41 |
0.63 |
0.0 |
Glyco:0/2 * Cl:0/2 |
MIBiG |
Source |
NC(=O)c1ccc(O)c(N=O)c1 |
view |
4-hydroxy-3-nitrosobenzamide |
|
|
celesticetin |
21 |
0.47 |
0.41 |
0.63 |
0.0 |
Glyco:0/2 * Cl:0/2 |
MIBiG |
Source |
CO[C@H](C)[C@@H](NC(=O)[C@@H]1CCCN1C)[C@H]1O[C@H](SCCOC(=O)c2ccccc2O)[C@H](O)[C@@H](O)[C@H]1O |
view |
celesticetin |
|
|
vanchrobactin |
22 |
0.47 |
0.45 |
0.61 |
0.0 |
Glyco:0/2 * Cl:0/2 |
MIBiG |
Source |
NC(N)=NCCC[C@@H](NC(=O)c1cccc(O)c1O)C(=O)N[C@@H](CO)C(=O)O |
view |
vanchrobactin |
|
|
nocardicin A |
23 |
0.46 |
0.4 |
0.63 |
0.0 |
Glyco:0/2 * Cl:0/2 |
MIBiG |
Source |
N[C@H](CCOc1ccc(/C(=N\O)C(=O)N[C@H]2CN([C@@H](C(=O)O)c3ccc(O)cc3)C2=O)cc1)C(=O)O |
view |
nocardicin A |
|
|
pseurotin |
24 |
0.46 |
0.43 |
0.6 |
0.0 |
Glyco:0/2 * Cl:0/2 |
MIBiG |
Source |
CC/C=C\[C@H](O)[C@H](O)C1=C(C)C(=O)[C@]2(O1)C(=O)N[C@@](OC)(C(=O)c1ccccc1)[C@@H]2O |
view |
pseurotin |
|
|
AM-toxin |
25 |
0.46 |
0.42 |
0.6 |
0.0 |
Glyco:0/2 * Cl:0/2 |
MIBiG |
Source |
C=C1NC(=O)C(CCc2ccc(OC)cc2)NC(=O)C(C(C)C)OC(=O)C(C)NC1=O |
view |
AM-toxin |
|
|
Obafluorin |
26 |
0.45 |
0.41 |
0.6 |
0.0 |
Glyco:0/2 * Cl:0/2 |
MIBiG |
Source |
O=C(N[C@@H]1C(=O)O[C@@H]1Cc1ccc([N+](=O)[O-])cc1)c1cccc(O)c1O |
view |
Obafluorin |
|
|
benzoxazinone DIMBOA |
27 |
0.45 |
0.41 |
0.59 |
0.0 |
Glyco:0/2 * Cl:0/2 |
MIBiG |
Source |
COc1ccc2c(c1)OC(O)C(=O)N2O |
view |
benzoxazinone DIMBOA |
|
|
myxochelin A |
28 |
0.45 |
0.42 |
0.58 |
0.0 |
Glyco:0/2 * Cl:0/2 |
MIBiG |
Source |
O=C(NCCCC[C@@H](CO)NC(=O)c1cccc(O)c1O)c1cccc(O)c1O |
view |
myxochelin A |
|
|
azaspirene |
29 |
0.45 |
0.43 |
0.57 |
0.0 |
Glyco:0/2 * Cl:0/2 |
MIBiG |
Source |
CC/C=C/C=C/C1=C(C)C(=O)C2(O1)C(=O)N[C@@](O)(Cc1ccccc1)[C@@H]2O |
view |
azaspirene |
|
|
Benzylpenicillin |
30 |
0.45 |
0.45 |
0.56 |
0.0 |
Glyco:0/2 * Cl:0/2 |
MIBiG |
Source |
CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)[O-].[Na+] |
view |
Benzylpenicillin |
|
|
porothramycin |
31 |
0.44 |
0.42 |
0.57 |
0.0 |
Glyco:0/2 * Cl:0/2 |
MIBiG |
Source |
COc1cccc2c1N[C@H](O)C1CC(/C=C/C(=O)N(C)C)=CN1C2=O |
view |
porothramycin |
|
|
Promysalin |
32 |
0.43 |
0.41 |
0.56 |
0.0 |
Glyco:0/2 * Cl:0/2 |
MIBiG |
Source |
CCCCCCC(CCCCCC(O)C(N)=O)OC(=O)C1CC=CN1C(=O)c1ccccc1O |
view |
Promysalin |
|
|
nogalaviketone |
37 |
0.42 |
0.43 |
0.51 |
0.0 |
Glyco:0/2 * Cl:0/2 |
MIBiG |
Source |
COC(=O)[C@@H]1c2cc3c(c(O)c2C(=O)C[C@]1(C)O)C(=O)c1c(O)cccc1C3=O |
view |
nogalaviketone |
|
|
gaudimycin A |
38 |
0.42 |
0.44 |
0.5 |
0.0 |
Glyco:0/2 * Cl:0/2 |
MIBiG |
Source |
CC1=CC(=O)[C@]2(O)C3=C(CC[C@]2(O)C1)C(=O)c1c(O)cccc1C3=O |
view |
gaudimycin A |
|
|
Rishirilide B |
39 |
0.41 |
0.42 |
0.51 |
0.0 |
Glyco:0/2 * Cl:0/2 |
MIBiG |
Source |
CC(C)CCC1(O)c2cc3c(O)cccc3cc2C(=O)C(C)C1(O)C(=O)O |
view |
Rishirilide B |
|
|
TAN-1612 |
40 |
0.41 |
0.42 |
0.5 |
0.0 |
Glyco:0/2 * Cl:0/2 |
MIBiG |
Source |
COc1cc(O)c2c(O)c3c(cc2c1)CC1(O)CC(=O)C(C(C)=O)=C(O)C1(O)C3=O |
view |
TAN-1612 |
|
|
gaudimycin C |
41 |
0.41 |
0.43 |
0.49 |
0.0 |
Glyco:0/2 * Cl:0/2 |
MIBiG |
Source |
CC1=CC(=O)[C@]2(O)C3=C(C(=O)c4c(O)cccc4C3=O)[C@@H](O)C[C@]2(O)C1 |
view |
gaudimycin C |
|
|
thalnumycin A |
42 |
0.41 |
0.43 |
0.49 |
0.0 |
Glyco:0/2 * Cl:0/2 |
MIBiG |
Source |
CCC1C(=O)c2c(cc3cccc(O)c3c2O)CC1(C)O |
view |
thalnumycin A |
|
|
5-hydroxyanthrotainin |
43 |
0.4 |
0.41 |
0.5 |
0.0 |
Glyco:0/2 * Cl:0/2 |
MIBiG |
Source |
COc1cc(O)c2c(O)c3c(cc2c1)[C@H](O)[C@@]1(O)CC(O)=C(C(N)=O)C(=O)[C@@]1(O)C3=O |
view |
5-hydroxyanthrotainin |
|
|
UWM6 |
44 |
0.4 |
0.42 |
0.48 |
0.0 |
Glyco:0/2 * Cl:0/2 |
MIBiG |
Source |
C[C@]1(O)CC(=O)[C@@H]2c3cc4cccc(O)c4c(O)c3C(=O)C[C@]2(O)C1 |
view |
UWM6 |
|
|
rabelomycin |
45 |
0.4 |
0.42 |
0.48 |
0.0 |
Glyco:0/2 * Cl:0/2 |
MIBiG |
Source |
C[C@]1(O)CC(=O)c2c(cc(O)c3c2C(=O)c2cccc(O)c2C3=O)C1 |
view |
rabelomycin |
|
|
haliamide |
46 |
0.39 |
0.41 |
0.48 |
0.0 |
Glyco:0/2 * Cl:0/2 |
MIBiG |
Source |
C=CC(C)C/C(C)=C/C=C/C(C)NC(=O)c1ccccc1 |
view |
haliamide |
|
|
meleagrin |
47 |
0.39 |
0.41 |
0.47 |
0.0 |
Glyco:0/2 * Cl:0/2 |
MIBiG |
Source |
C=CC(C)(C)C12C=C(O)C(=O)N3/C(=C\c4cnc[nH]4)C(=O)NC31N(OC)c1ccccc12 |
view |
meleagrin |
|
|
nogalonic acid |
48 |
0.39 |
0.43 |
0.46 |
0.0 |
Glyco:0/2 * Cl:0/2 |
MIBiG |
Source |
CC(=O)CC(=O)c1c(CC(=O)O)cc2c(c1O)C(=O)c1c(O)cccc1C2=O |
view |
nogalonic acid |
|
|
prejadomycin |
49 |
0.39 |
0.43 |
0.46 |
0.0 |
Glyco:0/2 * Cl:0/2 |
MIBiG |
Source |
CC1=CC(=O)[C@@H]2c3cc4cccc(O)c4c(O)c3C(=O)C[C@]2(O)C1 |
view |
prejadomycin |
|